Data / Drug companies / Kramer Laboratories
Kramer Laboratories: 26 products in the FDA NDC directory, labeler code 55505
Kramer Laboratories (labeler code 55505) lists 26 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 26 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 55505
- Products in commercial distribution
- 26
- Packages
- 48
- Finished drugs by generic name
- 10
- Prescription products
- 0
- Over the counter products
- 26
- Flagged as original packager
- 24 of 24 products that carry the flag
- Started marketing in the last 12 months
- 2
- Products with a marketing end date set
- 2
- Earliest marketing start
- November 15, 2018
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 22 | 84.6% |
| New drug applications (NDA) | 3 | 11.5% |
| Generic drugs (ANDA) | 1 | 3.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 26 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Bismuth subsalicylate | 6 | 80 |
| Tolnaftate | 6 | 99 |
| Ketoconazole | 3 | 35 |
| Dextromethorphan hydrobromide, and guaifenesin | 2 | 1 |
| Salicylic acid | 2 | 330 |
| Hydrocortisone | 1 | 171 |
| Colloidal oatmeal | 1 | 66 |
| Dextromethorphan hbr, doxylamine succinate | 1 | 12 |
| Simethicone | 1 | 86 |
| Minoxidil | 1 | 113 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 10 | 38.5% |
| Shampoo | 5 | 19.2% |
| Cream | 2 | 7.7% |
| Tablet | 2 | 7.7% |
| Tablet, coated | 1 | 3.8% |
| Aerosol, spray | 1 | 3.8% |
| Solution | 1 | 3.8% |
| Tablet, chewable | 1 | 3.8% |
| Aerosol, foam | 1 | 3.8% |
| Ointment | 1 | 3.8% |
| Spray | 1 | 3.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Nizoral Hair Regrowth Treatment for Men | 55505-237 | Aerosol, foam | Generic drugs (ANDA) | August 1, 2026 |
| Kaopectate | 55505-229 | Liquid | Over the counter monograph drugs | February 1, 2026 |
| Nizoral | 55505-232 | Shampoo | New drug applications (NDA) | October 1, 2025 |
| Fungi Nail Everyday Antifungal Powder | 55505-234 | Spray | Over the counter monograph drugs | January 1, 2025 |
| Nizoral | 55505-233 | Shampoo | New drug applications (NDA) | November 1, 2024 |
| SAFETUSSIN Non Drowsy Cough plus chest congestion | 55505-231 | Tablet | Over the counter monograph drugs | May 17, 2024 |
| SAFETUSSIN MAX STRENGTH MS Cough, Cold and Flu | 55505-230 | Tablet | Over the counter monograph drugs | May 17, 2024 |
| Nizoral Psoriasis Relief | 55505-224 | Cream | Over the counter monograph drugs | January 1, 2024 |
| Nizoral Eczema Relief Cream | 55505-223 | Cream | Over the counter monograph drugs | January 1, 2024 |
| Nizoral Scalp Itch Relief | 55505-222 | Shampoo | Over the counter monograph drugs | January 1, 2024 |
| Safetussin PM Nighttime Cough relief | 55505-221 | Liquid | Over the counter monograph drugs | July 28, 2023 |
| SAFETUSSIN Non Drowsy Cough plus chest congestion | 55505-220 | Liquid | Over the counter monograph drugs | June 1, 2023 |
| Safetussin High Blood Pressure and diabetes Cough, Cold and Flu | 55505-217 | Liquid | Over the counter monograph drugs | April 17, 2023 |
| Opti-Nail 2-in-1 | 55505-219 | Liquid | Over the counter monograph drugs | January 20, 2023 |
| Nizoral | 55505-196 | Shampoo | New drug applications (NDA) | June 16, 2022 |
| Kaopectate | 55505-206 | Tablet, chewable | Over the counter monograph drugs | February 1, 2021 |
| Nizoral Psoriasis | 55505-202 | Shampoo | Over the counter monograph drugs | December 1, 2020 |
| Kaopectate Max Peppermint Flavor Anti Diarrheal | 55505-200 | Liquid | Over the counter monograph drugs | November 1, 2020 |
| Kaopectate Peppermint Flavor Anti Diarrheal | 55505-199 | Liquid | Over the counter monograph drugs | October 1, 2020 |
| Kaopectate Vanilla Flavor Anti Diarrheal | 55505-198 | Liquid | Over the counter monograph drugs | October 1, 2020 |
| Kaopectate | 55505-197 | Tablet, coated | Over the counter monograph drugs | October 1, 2020 |
| EXTRA STRENGTH gas relief | 55505-225 | Liquid | Over the counter monograph drugs | August 26, 2020 |
| HC Max Anti-Fungal | 55505-195 | Aerosol, spray | Over the counter monograph drugs | May 28, 2020 |
| Fungi Nail Anti-Fungal Pen | 55505-193 | Liquid | Over the counter monograph drugs | March 1, 2020 |
| Fungi Nail Toe and Foot | 55505-177 | Solution | Over the counter monograph drugs | March 25, 2019 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.